$MDXG
MIMEDX GROUP, INC. Stock $mdxg

$mdxg Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-K Financial Statement

#000137633921000011 Filed on March 08, 2021

Income Statement

Concept	2020 Q4	2020	2019 Q4
Revenue	$68.55M	$248.2M	$76.40M
YoY Change	-10.28%	-17.05%	-17.48%
Cost Of Revenue	$10.82M	$39.33M	$12.71M
YoY Change	-14.87%	-8.71%	22.21%
Gross Profit	$57.73M	$208.9M	$63.69M
YoY Change	-9.36%	-18.45%	-22.5%
Gross Profit Margin	84.22%	84.16%	83.37%
Selling, General & Admin	$48.71M	$181.0M	$45.44M
YoY Change	7.2%	-8.67%	-31.46%
% of Gross Profit	84.38%	86.65%	71.34%
Research & Development	$3.430M	$11.72M	$2.720M
YoY Change	26.1%	5.16%	-40.09%
% of Gross Profit	5.94%	5.61%	4.27%
Depreciation & Amortization	$1.540M	$5.782M	$1.840M
YoY Change	-16.3%	-11.67%	-17.12%
% of Gross Profit	2.67%	2.77%	2.89%
Operating Expenses	$52.39M	$192.7M	$48.43M
YoY Change	8.18%	-7.93%	-31.89%
Operating Profit	$5.340M	-$45.40M	$15.26M
YoY Change	-65.01%	114.55%	37.82%
Interest Expense	-$1.510M	-$7.900M	-$2.400M
YoY Change	-37.08%	68.09%	-1190.91%
% of Operating Profit	-28.28%		-15.73%
Other Income/Expense, Net	$0.00	-$3.000K	$10.00K
YoY Change	-100.0%	-101.06%
Pretax Income	-$17.60M	-$61.54M	-$7.260M
YoY Change	142.42%	140.54%	-16.84%
Income Tax	-$1.020M	-$12.26M	$220.0K
% Of Pretax Income
Net Earnings	-$16.58M	-$49.28M	-$7.476M
YoY Change	121.78%	92.67%	-79.36%
Net Earnings / Revenue	-24.19%	-19.85%	-9.79%
Basic Earnings Per Share	-$0.17	-$0.77	-$0.07
Diluted Earnings Per Share	-$0.17	-$0.77	-$0.07
COMMON SHARES
Basic Shares Outstanding	111.0M shares	108.3M shares
Diluted Shares Outstanding		108.3M shares

Balance Sheet

Concept	2020 Q4	2020	2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$95.80M	$95.80M	$69.10M
YoY Change	38.64%	38.64%
Cash & Equivalents	$95.81M	$95.80M	$69.07M
Short-Term Investments
Other Short-Term Assets	$3.371M	$9.000M	$6.058M
YoY Change	-44.35%	-29.69%	4.13%
Inventory	$10.36M	$10.40M	$9.104M
Prepaid Expenses	$5.605M		$6.669M
Receivables	$35.42M	$35.40M	$32.33M
Other Receivables	$10.10M	$10.10M	$0.00
Total Short-Term Assets	$160.6M	$160.6M	$123.2M
YoY Change	30.32%	30.36%	66.44%
LONG-TERM ASSETS
Property, Plant & Equipment	$11.44M	$15.10M	$12.33M
YoY Change	-7.23%	-3.82%	-29.25%
Goodwill	$19.98M		$19.98M
YoY Change	0.0%		0.0%
Intangibles	$6.004M		$7.777M
YoY Change	-22.8%		-19.06%
Long-Term Investments
YoY Change
Other Assets	$375.0K	$400.0K	$443.0K
YoY Change	-15.35%	0.0%	-75.21%
Total Long-Term Assets	$41.42M	$41.40M	$43.92M
YoY Change	-5.71%	-5.91%	-9.99%
TOTAL ASSETS
Total Short-Term Assets	$160.6M	$160.6M	$123.2M
Total Long-Term Assets	$41.42M	$41.40M	$43.92M
Total Assets	$202.0M	$202.0M	$167.2M
YoY Change	20.86%	20.81%	36.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.765M	$8.800M	$8.710M
YoY Change	0.63%	1.15%	-41.4%
Accrued Expenses	$30.46M	$50.10M	$32.16M
YoY Change	-5.29%	-8.24%	1.0%
Deferred Revenue	$554.0K
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00	$3.750M
YoY Change	-100.0%	-100.0%
Total Short-Term Liabilities	$59.16M	$59.20M	$67.32M
YoY Change	-12.12%	-12.04%	-5.91%
LONG-TERM LIABILITIES
Long-Term Debt	$47.70M	$47.70M	$61.91M
YoY Change	-22.95%	-22.94%
Other Long-Term Liabilities	$3.755M	$3.800M	$3.540M
YoY Change	6.07%	8.57%	115.59%
Total Long-Term Liabilities	$51.45M	$51.50M	$65.45M
YoY Change	-21.38%	-21.25%	3885.75%
TOTAL LIABILITIES
Total Short-Term Liabilities	$59.16M	$59.20M	$67.32M
Total Long-Term Liabilities	$51.45M	$51.50M	$65.45M
Total Liabilities	$110.6M	$110.6M	$132.8M
YoY Change	-16.69%	-16.72%	81.4%
SHAREHOLDERS EQUITY
Retained Earnings	-$151.4M		-$102.1M
YoY Change	48.25%		33.41%
Common Stock	$113.0K		$113.0K
YoY Change	0.0%		0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$7.449M		$10.81M
YoY Change	-31.07%		-72.04%
Treasury Stock Shares	1.774M shares		1.885M shares
Shareholders Equity	-$150.0K	$91.40M	$34.40M
YoY Change
Total Liabilities & Shareholders Equity	$202.0M	$202.0M	$167.2M
YoY Change	20.86%	20.81%	36.08%

Cashflow Statement

Concept	2020 Q4	2020	2019 Q4
OPERATING ACTIVITIES
Net Income	-$16.58M	-$49.28M	-$7.476M
YoY Change	121.78%	92.67%	-79.36%
Depreciation, Depletion And Amortization	$1.540M	$5.782M	$1.840M
YoY Change	-16.3%	-11.67%	-17.12%
Cash From Operating Activities	-$10.26M	-$30.26M	-$23.12M
YoY Change	-55.62%	-23.21%	-1601.3%
INVESTING ACTIVITIES
Capital Expenditures	-$2.280M	-$4.560M	-$790.0K
YoY Change	188.61%	105.41%	-59.9%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Cash From Investing Activities	-$2.280M	-$4.555M	-$800.0K
YoY Change	185.0%	-1003.77%	-32.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$900.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.240M	$61.56M	-1.140M
YoY Change	8.77%	-2.06%	307.14%
NET CHANGE
Cash From Operating Activities	-10.26M	-$30.26M	-23.12M
Cash From Investing Activities	-2.280M	-$4.555M	-800.0K
Cash From Financing Activities	-1.240M	$61.56M	-1.140M
Net Change In Cash	-13.78M	$26.74M	-25.06M
YoY Change	-45.01%	11.66%	-35900.0%
FREE CASH FLOW
Cash From Operating Activities	-$10.26M	-$30.26M	-$23.12M
Capital Expenditures	-$2.280M	-$4.560M	-$790.0K
Free Cash Flow	-$7.980M	-$25.70M	-$22.33M
YoY Change	-64.26%	-30.89%	-736.18%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020	dei	Entity Central Index Key EntityCentralIndexKey	0001376339
CY2020	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020	dei	Amendment Flag AmendmentFlag	false
CY2020	dei	Entity Address City Or Town EntityAddressCityOrTown	Marietta
CY2020	dei	Local Phone Number LocalPhoneNumber	651-9100
CY2020	dei	Security12g Title Security12gTitle	Common Stock, par value $0.001 per share
CY2020	dei	Entity Address State Or Province EntityAddressStateOrProvince	GA
CY2020	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	30062
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	us-gaap:OtherAssetsNoncurrent
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	us-gaap:OtherAssetsNoncurrent
CY2019Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	us-gaap:OtherLiabilitiesCurrent
CY2020Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	us-gaap:OtherLiabilitiesCurrent
CY2020Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	us-gaap:OtherLiabilitiesCurrent
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	us-gaap:OtherLiabilitiesNoncurrent
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	us-gaap:OtherLiabilitiesNoncurrent
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	us-gaap:OtherLiabilitiesNoncurrent
CY2020	dei	Document Type DocumentType	10-K
CY2020	dei	Document Annual Report DocumentAnnualReport	true
CY2020	dei	Document Period End Date DocumentPeriodEndDate	2020-12-31
CY2020	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020	dei	Document Transition Report DocumentTransitionReport	false
CY2020	dei	Entity File Number EntityFileNumber	001-35887
CY2020	dei	Entity Registrant Name EntityRegistrantName	MIMEDX GROUP, INC.
CY2020	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
CY2020	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-2792552
CY2020	dei	Entity Address Address Line1 EntityAddressAddressLine1	1775 West Oak Commons Court, NE
CY2020	dei	City Area Code CityAreaCode	770
CY2020	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2020	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2020	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2020	dei	Entity Small Business EntitySmallBusiness	false
CY2020	dei	Entity Small Business EntitySmallBusiness	false
CY2020	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2020	dei	Entity Shell Company EntityShellCompany	false
CY2020Q2	dei	Entity Public Float EntityPublicFloat	537700000	USD
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	111261154	shares
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	69069000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	95812000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	35423000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	32327000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	10361000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	9104000	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	5605000	USD
CY2019Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	6669000	USD
CY2020Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	10045000	USD
CY2019Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	18000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	3371000	USD
CY2019Q4	us-gaap	Other Assets Current OtherAssetsCurrent	6058000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	160617000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	123245000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11437000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12328000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3397000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3623000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	19976000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	19976000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6004000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7777000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	375000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	443000	USD
CY2020Q4	us-gaap	Assets Assets	202032000	USD
CY2019Q4	us-gaap	Assets Assets	167166000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8765000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8710000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	18467000	USD
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	21302000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	30460000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	32161000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2019Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	3750000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1470000	USD
CY2019Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1399000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	59162000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	67322000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	47697000	USD
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	61906000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3755000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3540000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	110614000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	132768000	USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	100000	shares
CY2020Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	100000	shares
CY2020Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	100000	shares
CY2019Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2019Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0	shares
CY2019Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	0	shares
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	91568000	USD
CY2019Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	USD
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	187500000	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	112703926	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	110930243	shares
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	112703926	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	110818649	shares
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	113000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	113000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	158610000	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	147231000	USD
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	1773683	shares
CY2019Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	1885277	shares
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	7449000	USD
CY2019Q4	us-gaap	Treasury Stock Value TreasuryStockValue	10806000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-151424000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-102140000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-150000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	34398000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	202032000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	167166000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	248234000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	299255000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	359111000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	39330000	USD
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	43081000	USD
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	36386000	USD
CY2020	us-gaap	Gross Profit GrossProfit	208904000	USD
CY2019	us-gaap	Gross Profit GrossProfit	256174000	USD
CY2018	us-gaap	Gross Profit GrossProfit	322725000	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	181022000	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	198205000	USD
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	258528000	USD
CY2020	mdxg	Investigation Restatementand Related InvestigationRestatementandRelated	59465000	USD
CY2019	mdxg	Investigation Restatementand Related InvestigationRestatementandRelated	66504000	USD
CY2018	mdxg	Investigation Restatementand Related InvestigationRestatementandRelated	51322000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11715000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11140000	USD
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	15765000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1073000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1039000	USD
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1034000	USD
CY2020	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	1027000	USD
CY2019	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	446000	USD
CY2018	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-45398000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-21160000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-3924000	USD
CY2020	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-8201000	USD
CY2019	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	USD
CY2018	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	USD
CY2020	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-7941000	USD
CY2019	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-4708000	USD
CY2018	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	527000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	283000	USD
CY2018	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-61543000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-25585000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-3397000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-12259000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	26582000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-49284000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-29979000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-83328000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-25580000	USD
CY2018	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-29979000	USD
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.77
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.77
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.24
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	108257112	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	106946384	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105596256	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108257112	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	106946384	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	105596256	shares
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	73797000	USD
CY2018	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	14768000	USD
CY2018	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3555000	USD
CY2018	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2018	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	0	USD
CY2018	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	7572000	USD
CY2018	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	4914000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-29979000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	49655000	USD
CY2019	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	11689000	USD
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	108000	USD
CY2019	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2019	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	0	USD
CY2019	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1474000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-25580000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	34398000	USD
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	32954000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	32028000	USD
CY2020	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	15733000	USD
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	411000	USD
CY2020	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2020	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	0	USD
CY2020	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	2334000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-49284000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-150000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-49284000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-25580000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-29979000	USD
CY2020	mdxg	Effect Of Change In Accounting Principle EffectOfChangeInAccountingPrinciple	0	USD
CY2019	mdxg	Effect Of Change In Accounting Principle EffectOfChangeInAccountingPrinciple	-17382000	USD
CY2020	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	1027000	USD
CY2018	mdxg	Effect Of Change In Accounting Principle EffectOfChangeInAccountingPrinciple	0	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	15357000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	12064000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	14768000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-8201000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2018	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2020	us-gaap	Depreciation Depreciation	5782000	USD
CY2019	us-gaap	Depreciation Depreciation	6546000	USD
CY2018	us-gaap	Depreciation Depreciation	5882000	USD
CY2020	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2276000	USD
CY2019	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1431000	USD
CY2018	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	137000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1073000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1039000	USD
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1034000	USD
CY2018	mdxg	Operating Lease Rightofuse Asset Amortization OperatingLeaseRightofuseAssetAmortization	0	USD
CY2020	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	10000	USD
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-1000	USD
CY2019	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	1258000	USD
CY2018	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	USD
CY2020	mdxg	Operating Lease Rightofuse Asset Amortization OperatingLeaseRightofuseAssetAmortization	983000	USD
CY2019	mdxg	Operating Lease Rightofuse Asset Amortization OperatingLeaseRightofuseAssetAmortization	947000	USD
CY2019	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	0	USD
CY2018	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	0	USD
CY2019	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-318000	USD
CY2018	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2020	mdxg	Amortizationof Discounton Notes Receivable AmortizationofDiscountonNotesReceivable	0	USD
CY2019	mdxg	Amortizationof Discounton Notes Receivable AmortizationofDiscountonNotesReceivable	0	USD
CY2018	mdxg	Amortizationof Discounton Notes Receivable AmortizationofDiscountonNotesReceivable	190000	USD
CY2020	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	0	USD
CY2019	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	0	USD
CY2018	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	25541000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3096000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	10938000	USD
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	0	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1257000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-6882000	USD
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6519000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-1064000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-4000	USD
CY2018	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	4548000	USD
CY2020	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	119000	USD
CY2019	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	5770000	USD
CY2018	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-3562000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	177000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-6171000	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	6585000	USD
CY2020	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	-2459000	USD
CY2019	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	-1722000	USD
CY2018	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	2083000	USD
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1746000	USD
CY2019	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-57000	USD
CY2018	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	16074000	USD
CY2020	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	10027000	USD
CY2019	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-436000	USD
CY2018	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-202000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-1718000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-2717000	USD
CY2018	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	1164000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-30263000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-39412000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	35796000	USD
CY2020	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	4228000	USD
CY2019	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	1752000	USD
CY2018	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	9419000	USD
CY2019	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2018	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2018	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	609000	USD
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	327000	USD
CY2019	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	466000	USD
CY2020	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	0	USD
CY2019	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	2722000	USD
CY2018	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	778000	USD
CY2019	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2018	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	30000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4555000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	504000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-9220000	USD
CY2020	mdxg	Proceedsfrom Issuanceof Temporary Equity ProceedsfromIssuanceofTemporaryEquity	100000000	USD
CY2019	mdxg	Proceedsfrom Issuanceof Temporary Equity ProceedsfromIssuanceofTemporaryEquity	0	USD
CY2018	mdxg	Proceedsfrom Issuanceof Temporary Equity ProceedsfromIssuanceofTemporaryEquity	0	USD
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	7470000	USD
CY2020	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	59500000	USD
CY2019	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	72750000	USD
CY2018	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	0	USD
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	3235000	USD
CY2019	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	6650000	USD
CY2018	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2020	us-gaap	Repayments Of Medium Term Notes RepaymentsOfMediumTermNotes	83872000	USD
CY2019	us-gaap	Repayments Of Medium Term Notes RepaymentsOfMediumTermNotes	1875000	USD
CY2018	us-gaap	Repayments Of Medium Term Notes RepaymentsOfMediumTermNotes	0	USD
CY2020	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	1439000	USD
CY2019	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	USD
CY2018	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	USD
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2334000	USD
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1474000	USD
CY2018	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	4914000	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	411000	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	108000	USD
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3555000	USD
CY2020	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	0	USD
CY2019	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	0	USD
CY2018	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	7572000	USD
CY2020	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	0	USD
CY2019	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	0	USD
CY2018	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	3000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	61561000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	62859000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-8934000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	26743000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	23951000	USD
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	17642000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	69069000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	45118000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27476000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	95812000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	69069000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	45118000	USD
CY2020	us-gaap	Nature Of Operations NatureOfOperations	Nature of Business<div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MiMedx Group, Inc. (together with its subsidiaries, except where the context otherwise requires, “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MiMedx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,” or the “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">”) </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">an industry leader in utilizing birth tissue as a platform for regenerative medicine, developing and distributing placental tissue allografts with patent-protected, proprietary processes for multiple sectors of healthcare. As a pioneer in placental biologics, we have both a core business, focused on addressing the needs of patients with acute and chronic non-healing wounds, and a promising late-stage pipeline targeted at decreasing pain and improving function for patients with degenerative musculoskeletal conditions. We derive our products from human placental tissues and process these tissues using our proprietary processing methods, including the PURION® process. We employ Current Good Tissue Practices, Current Good Manufacturing Practices, and terminal sterilization to produce our allografts. MiMedx provides products primarily in the wound care, burn, surgical, and non-operative sports medicine sectors of healthcare. All of our products are regulated by the FDA.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s business model is focused primarily on the United States of America but the Company is pursuing opportunities for international expansion. </span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Effect of the COVID-19 Pandemic</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 11, 2020, the World Health Organization designated the outbreak of a novel strain of coronavirus as a global pandemic (the “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pandemic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">” or “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19 Pandemic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">”). The COVID-19 pandemic and associated governmental and societal responses have affected the Company’s business, results of operations and financial condition. The continuation or additional waves of the outbreak of the COVID-19 pandemic or the outbreak of other health epidemics could harm the Company’s operations, hinder the Company’s ability to generate revenue, or increase the Company’s costs and expenses. The ultimate impact of the pandemic is highly uncertain. As a result of the pandemic, the Company has experienced delays and impacts on the business and clinical trials. It is uncertain the extent and how long the pandemic will affect the healthcare system and the global economy as a whole. The effects of the pandemic or other health epidemics could continue to have an adverse impact on the Company’s business, results of operations, and financial condition in the future.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (the “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CARES Act</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">”) was signed into law. The CARES Act includes provisions relating to refundable payroll tax credits, deferment of the employer portion of certain payroll taxes, loans, and grants to certain businesses, net operating loss carryback periods, alternative minimum tax credit refunds, modifications to the net interest deduction limitations and technical corrections to tax depreciation methods for qualified improvement property. Certain of these provisions were extended or expanded as a result of the Consolidated Appropriations Act, 2021, which was signed into law on December 27, 2020. As a result of these laws, the Company recorded a federal tax benefit of approximately $11.3 million due to the release of a previously-recorded valuation allowance. Of this amount, the Company received $1.2 million during the year ended December 31, 2020. The remaining $10.1 million is recorded as part of income tax receivable on the consolidated balance sheet as of December 31, 2020.</span></div>
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">GAAP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">”) in the United States of America (“</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">”). Generally accepted accounting principles require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported consolidated statements of operations during the reporting period. Actual results could differ from those estimates. Significant estimates include estimated useful lives and potential impairment of property and equipment, goodwill and intangible assets, estimates of loss for contingent liabilities, estimate of allowance for doubtful accounts, management’s assessment of the Company’s ability to continue as a going concern, estimate of fair value of share-based payments, and valuation of deferred tax assets.</span></div>
CY2020	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2020	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	Market Concentrations and Credit Risk<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company places its cash and cash equivalents on deposit with U.S.-based financial institutions. The U.S. Federal Deposit Insurance Corporation (“</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FDIC</span>”) provides insurance coverage for deposits up to $250,000 for substantially all depository accounts.
CY2020Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	USD
CY2020Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	95100000	USD
CY2019Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	68400000	USD
CY2020	mdxg	Numberof Depository Institutions NumberofDepositoryInstitutions	4	depositoryInstitution
CY2020	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	1000000.0	USD
CY2019	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	500000	USD
CY2018	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	USD
CY2020	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	reportingUnit
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2019	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2018	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	300000	USD
CY2019	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	500000	USD
CY2018	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	600000	USD
CY2019Q3	mdxg	Contract With Customer Liability Before Write Offs ContractWithCustomerLiabilityBeforeWriteOffs	48883000	USD
CY2019Q3	us-gaap	Contract With Customer Asset Gross ContractWithCustomerAssetGross	6415000	USD
CY2019Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	9006000	USD
CY2019Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1261000	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1239000	USD
CY2020Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	174000	USD
CY2018Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	51000000.0	USD
CY2020	mdxg	Group Purchasing Organization Administrative Feesas Percentof Purchase Volume GroupPurchasingOrganizationAdministrativeFeesasPercentofPurchaseVolume	0.03
CY2020Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	200000	USD
CY2019Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1300000	USD
CY2020	us-gaap	Advertising Expense AdvertisingExpense	100000	USD
CY2019	us-gaap	Advertising Expense AdvertisingExpense	100000	USD
CY2018	us-gaap	Advertising Expense AdvertisingExpense	100000	USD
CY2020Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	328000	USD
CY2019Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	318000	USD
CY2020Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	4543000	USD
CY2019Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	4299000	USD
CY2020Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	6329000	USD
CY2019Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5206000	USD
CY2020Q4	us-gaap	Inventory Gross InventoryGross	11200000	USD
CY2019Q4	us-gaap	Inventory Gross InventoryGross	9823000	USD
CY2020Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	839000	USD
CY2019Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	719000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	10361000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	9104000	USD
CY2019Q4	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	3500000	USD
CY2020Q4	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	3400000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	40935000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	36305000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	29498000	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	23977000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11437000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12328000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1176000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1168000	USD
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y4M24D
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2960000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2919000	USD
CY2020	us-gaap	Depreciation Depreciation	5782000	USD
CY2019	us-gaap	Depreciation Depreciation	6546000	USD
CY2018	us-gaap	Depreciation Depreciation	5882000	USD
CY2020	mdxg	Number Of Subleased Warehouse Spaces NumberOfSubleasedWarehouseSpaces	1	warehouseSpace
CY2020	us-gaap	Sublease Income SubleaseIncome	100000	USD
CY2019	us-gaap	Sublease Income SubleaseIncome	0	USD
CY2018	us-gaap	Operating Leases Income Statement Sublease Revenue OperatingLeasesIncomeStatementSubleaseRevenue	0	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3623000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3397000	USD
CY2019Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y1M6D
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.100
CY2019Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.115
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	1392000	USD
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	1469000	USD
CY2020	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	983000	USD
CY2019	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	947000	USD
CY2018	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1500000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1537000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1566000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	507000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	339000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	339000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	705000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4993000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	857000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	4136000	USD
CY2020Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	800000	USD
CY2019Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	0	USD
CY2020	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	reportingUnit
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2018Q4	us-gaap	Goodwill Goodwill	19976000	USD
CY2019	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0	USD
CY2019Q4	us-gaap	Goodwill Goodwill	19976000	USD
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1034000	USD
CY2020	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	1027000	USD
CY2020	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0	USD
CY2020Q4	us-gaap	Goodwill Goodwill	19976000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	11285000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7334000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3951000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	14394000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	8755000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5639000	USD
CY2020Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	13338000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6004000	USD
CY2019Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	16532000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7777000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1073000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1039000	USD
CY2019	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	1258000	USD
CY2018	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	793000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	691000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	691000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	691000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	279000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	806000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3951000	USD
CY2020Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	14822000	USD
CY2019Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	12202000	USD
CY2020Q4	mdxg	Accrued Settlement Costs Current AccruedSettlementCostsCurrent	9975000	USD
CY2019Q4	mdxg	Accrued Settlement Costs Current AccruedSettlementCostsCurrent	12825000	USD
CY2020Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	688000	USD
CY2019Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	2581000	USD
CY2020Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	2141000	USD
CY2019Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	1722000	USD
CY2020Q4	mdxg	Accrued Clinical Trials Current AccruedClinicalTrialsCurrent	651000	USD
CY2019Q4	mdxg	Accrued Clinical Trials Current AccruedClinicalTrialsCurrent	1076000	USD
CY2020Q4	mdxg	Accrued Rebates AccruedRebates	886000	USD
CY2019Q4	mdxg	Accrued Rebates AccruedRebates	142000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1297000	USD
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1613000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	30460000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	32161000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	50000000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	0	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	50000000	USD
CY2018	mdxg	Debt Instrument Convertible Beneficial Conversion Feature Amortization DebtInstrumentConvertibleBeneficialConversionFeatureAmortization	0	USD
CY2020	mdxg	Temporary Equity Accretionof Increasingrate Dividend Feature TemporaryEquityAccretionofIncreasingrateDividendFeature	918000	USD
CY2019	mdxg	Temporary Equity Accretionof Increasingrate Dividend Feature TemporaryEquityAccretionofIncreasingrateDividendFeature	0	USD
CY2020Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-8200000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-49284000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-25580000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-29979000	USD
CY2020	mdxg	Temporary Equity Accretedbut Unrecorded Dividends TemporaryEquityAccretedbutUnrecordedDividends	2016000	USD
CY2019	mdxg	Temporary Equity Accretedbut Unrecorded Dividends TemporaryEquityAccretedbutUnrecordedDividends	0	USD
CY2018	mdxg	Temporary Equity Accretedbut Unrecorded Dividends TemporaryEquityAccretedbutUnrecordedDividends	0	USD
CY2020	mdxg	Debt Instrument Convertible Beneficial Conversion Feature Amortization DebtInstrumentConvertibleBeneficialConversionFeatureAmortization	31110000	USD
CY2019	mdxg	Debt Instrument Convertible Beneficial Conversion Feature Amortization DebtInstrumentConvertibleBeneficialConversionFeatureAmortization	0	USD
CY2018	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	3803000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	11565000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	8983000	USD
CY2018	mdxg	Temporary Equity Accretionof Increasingrate Dividend Feature TemporaryEquityAccretionofIncreasingrateDividendFeature	0	USD
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	106946384	shares
CY2020	mdxg	Adjustmentsto Reconcileto Net Income Loss Availableto Common Stockholders AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders	34044000	USD
CY2019	mdxg	Adjustmentsto Reconcileto Net Income Loss Availableto Common Stockholders AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders	0	USD
CY2018	mdxg	Adjustmentsto Reconcileto Net Income Loss Availableto Common Stockholders AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders	0	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-83328000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-25580000	USD
CY2018	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-29979000	USD
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	108257112	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105596256	shares
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.77
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-83328000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-25580000	USD
CY2018	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-29979000	USD
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	106946384	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	351351	shares
CY2020	mdxg	Adjustmentsto Reconcileto Net Income Loss Availableto Common Stockholders AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders	34044000	USD
CY2019	mdxg	Adjustmentsto Reconcileto Net Income Loss Availableto Common Stockholders AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders	0	USD
CY2018	mdxg	Adjustmentsto Reconcileto Net Income Loss Availableto Common Stockholders AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders	0	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-83328000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-25580000	USD
CY2018	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-29979000	USD
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	108257112	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105596256	shares
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.77
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.24
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2020	mdxg	Adjustmentsto Reconcileto Net Income Loss Availableto Common Stockholders AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders	34000000.0	USD
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	15687044	shares
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2135806	shares
CY2018	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3538921	shares
CY2020	mdxg	Number Of Share Based Compensation Plans NumberOfShareBasedCompensationPlans	2	plan
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2020	mdxg	Debt Instrument Convertible Beneficial Conversion Feature Amortization DebtInstrumentConvertibleBeneficialConversionFeatureAmortization	31100000	USD
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2885334	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.42
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	508300	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.62
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2025683	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	5.90
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2025683	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.62
CY2020	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P2Y1M6D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	9054128	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	4.62
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P2Y1M6D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	9054128	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1900000	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	600000	USD
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	7900000	USD
CY2020	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	1600000	USD
CY2019	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	200000	USD
CY2018	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	5900000	USD
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	0	USD
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1400000	USD
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	100000	USD
CY2018	mdxg	Lease Right Of Use Asset And Liability LeaseRightOfUseAssetAndLiability	0	USD
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2020Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	1300000	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	300000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	15357000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12064000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14768000	USD
CY2020	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	3792000	USD
CY2019	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	3081000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	10965000	USD
CY2018	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	507600	shares
CY2018	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	7600000	USD
CY2020	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	148972	shares
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	900000	USD
CY2020Q4	mdxg	Deferred Employer Payroll Taxes Cares Act DeferredEmployerPayrollTaxesCARESAct	2200000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	17010000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	14350000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	5920000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	2349000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3259000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3439000	USD
CY2020Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	2992000	USD
CY2019Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	839000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	2918000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	3759000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Legal Settlements DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements	2464000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Legal Settlements DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements	3276000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	2138000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	4859000	USD
CY2020Q4	mdxg	Deferred Tax Asset Lease Obligation DeferredTaxAssetLeaseObligation	1021000	USD
CY2019Q4	mdxg	Deferred Tax Asset Lease Obligation DeferredTaxAssetLeaseObligation	1044000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Returns And Allowances DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances	170000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Returns And Allowances DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances	659000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1075000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1285000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	1170000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	1189000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1073000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1582000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	895000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	35626000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	868000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	160000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	389000	USD
CY2020Q4	mdxg	Deferred Tax Liabilities Deferred Costof Goodssold DeferredTaxLiabilitiesDeferredCostofGoodssold	43000	USD
CY2019Q4	mdxg	Deferred Tax Liabilities Deferred Costof Goodssold DeferredTaxLiabilitiesDeferredCostofGoodssold	322000	USD
CY2020Q4	mdxg	Deferred Tax Liabilities Unearned Insurance Refund DeferredTaxLiabilitiesUnearnedInsuranceRefund	0	USD
CY2019Q4	mdxg	Deferred Tax Liabilities Unearned Insurance Refund DeferredTaxLiabilitiesUnearnedInsuranceRefund	894000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	30615000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	35626000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	30615000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2019Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2019Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	800000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	7.8833
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0020
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0136
CY2018	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.0352
CY2020	mdxg	Effective Income Tax Rate Reconciliation Nondeductible Expense Compensation Cost Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationCostPercent	0.0089
CY2019	mdxg	Effective Income Tax Rate Reconciliation Nondeductible Expense Compensation Cost Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationCostPercent	0.0149
CY2018	mdxg	Effective Income Tax Rate Reconciliation Nondeductible Expense Compensation Cost Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationCostPercent	0.1533
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Meals And Entertainment EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment	0.0050
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Meals And Entertainment EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment	0.0204
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Meals And Entertainment EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment	0.2416
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.0124
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.0505
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.1082
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.0032
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.0045
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.1975
CY2020	mdxg	Effective Income Tax Rate Reconciliation Writeoffof Net Operating Losses Percent EffectiveIncomeTaxRateReconciliationWriteoffofNetOperatingLossesPercent	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	-0.0024
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	-0.0122
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	0.0235
CY2019	mdxg	Effective Income Tax Rate Reconciliation Writeoffof Net Operating Losses Percent EffectiveIncomeTaxRateReconciliationWriteoffofNetOperatingLossesPercent	0
CY2018	mdxg	Effective Income Tax Rate Reconciliation Writeoffof Net Operating Losses Percent EffectiveIncomeTaxRateReconciliationWriteoffofNetOperatingLossesPercent	0.1181
CY2020	mdxg	Effective Income Tax Rate Reconciliation Adjustmentto Fixed Assets Percent EffectiveIncomeTaxRateReconciliationAdjustmenttoFixedAssetsPercent	0
CY2019	mdxg	Effective Income Tax Rate Reconciliation Adjustmentto Fixed Assets Percent EffectiveIncomeTaxRateReconciliationAdjustmenttoFixedAssetsPercent	0
CY2018	mdxg	Effective Income Tax Rate Reconciliation Adjustmentto Fixed Assets Percent EffectiveIncomeTaxRateReconciliationAdjustmenttoFixedAssetsPercent	-0.0533
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Percent EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent	-0.1099
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Percent EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent	0
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Percent EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.0166
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0012
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.0103
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.0814
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.1283
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.1992
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0002
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	7.8259
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-12418000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-53000	USD
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	614000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	159000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	48000	USD
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	427000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-12259000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-5000	USD
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1041000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-12259000	USD
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	19452000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2018	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	6089000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	25541000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	26582000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	35600000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	30600000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	13200000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	4000000.0	USD
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	11900000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	3100000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	627000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	938000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	847000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	56000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	91000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	150000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	367000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	477000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	627000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	938000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	0	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	600000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	0	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	100000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	100000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	100000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	100000	USD
CY2020	us-gaap	Interest Paid InterestPaid	7456000	USD
CY2019	us-gaap	Interest Paid InterestPaid	4331000	USD
CY2018	us-gaap	Interest Paid InterestPaid	197000	USD
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	208000	USD
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	308000	USD
CY2018	us-gaap	Income Taxes Paid IncomeTaxesPaid	859000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	1569000	USD
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	1650000	USD
CY2018	us-gaap	Operating Lease Payments OperatingLeasePayments	0	USD
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1062000	USD
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1184000	USD
CY2018	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1168000	USD
CY2020	mdxg	Noncash Activities Deferred Financing Costs NoncashActivitiesDeferredFinancingCosts	53000	USD
CY2019	mdxg	Noncash Activities Deferred Financing Costs NoncashActivitiesDeferredFinancingCosts	6650000	USD
CY2018	mdxg	Noncash Activities Deferred Financing Costs NoncashActivitiesDeferredFinancingCosts	0	USD
CY2020	mdxg	Noncash Activities Debt Instrument Amendment Fee NoncashActivitiesDebtInstrumentAmendmentFee	722000	USD
CY2019	mdxg	Noncash Activities Debt Instrument Amendment Fee NoncashActivitiesDebtInstrumentAmendmentFee	0	USD
CY2018	mdxg	Noncash Activities Debt Instrument Amendment Fee NoncashActivitiesDebtInstrumentAmendmentFee	0	USD
CY2020	mdxg	Lease Right Of Use Asset And Liability LeaseRightOfUseAssetAndLiability	1169000	USD
CY2019	mdxg	Lease Right Of Use Asset And Liability LeaseRightOfUseAssetAndLiability	0	USD
CY2020	mdxg	Fair Value Of Non Cash Consideration Received For Option Exercise FairValueOfNonCashConsiderationReceivedForOptionExercise	922000	USD
CY2019	mdxg	Fair Value Of Non Cash Consideration Received For Option Exercise FairValueOfNonCashConsiderationReceivedForOptionExercise	0	USD
CY2018	mdxg	Fair Value Of Non Cash Consideration Received For Option Exercise FairValueOfNonCashConsiderationReceivedForOptionExercise	0	USD
CY2020	mdxg	Defined Contribution Plan Period Of Service For Eligibility DefinedContributionPlanPeriodOfServiceForEligibility	P1M
CY2020	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.90
CY2020	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	19500	USD
CY2020	mdxg	Minimum Age For Additional Contribution Beyond Normal Plan MinimumAgeForAdditionalContributionBeyondNormalPlan	P50Y
CY2020	mdxg	Defined Benefit Plan Maximum Pre Tax Contributions By Plan Participants DefinedBenefitPlanMaximumPreTaxContributionsByPlanParticipants	6500	USD
CY2020	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.50
CY2020	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.05
CY2020	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	1500000	USD
CY2019	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	1500000	USD
CY2018	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	1900000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P3Y
CY2020Q4	us-gaap	Contractual Obligation Due In Next Twelve Months ContractualObligationDueInNextTwelveMonths	169000	USD
CY2020Q4	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	889000	USD
CY2020Q4	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	0	USD
CY2020Q4	us-gaap	Contractual Obligation ContractualObligation	1058000	USD
CY2020Q4	us-gaap	Litigation Reserve LitigationReserve	10000000.0	USD
CY2020	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	7400000	USD
CY2020	mdxg	Legal Settlement Amount Paid By Third Party LegalSettlementAmountPaidByThirdParty	3500000	USD
CY2019Q4	us-gaap	Litigation Reserve LitigationReserve	12800000	USD
CY2020Q4	mdxg	Numberof Distribution Channels NumberofDistributionChannels	2	distributionChannel
CY2017Q4	us-gaap	Restructuring Reserve RestructuringReserve	0	USD
CY2018Q4	us-gaap	Restructuring Reserve RestructuringReserve	5607000	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	53647000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	64303000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	248234000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	299255000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	359111000	USD
CY2018Q4	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated RestructuringAndRelatedCostNumberOfPositionsEliminated	240	position
CY2018Q4	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated Period Percent RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent	0.24
CY2019	us-gaap	Restructuring Charges RestructuringCharges	8500000	USD
CY2018	us-gaap	Restructuring Charges RestructuringCharges	6100000	USD
CY2019	us-gaap	Restructuring Charges RestructuringCharges	8543000	USD
CY2019	us-gaap	Payments For Restructuring PaymentsForRestructuring	10589000	USD
CY2019Q4	us-gaap	Restructuring Reserve RestructuringReserve	3561000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	88863000	USD
CY2019Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	76400000	USD
CY2018	us-gaap	Restructuring Charges RestructuringCharges	6055000	USD
CY2018	us-gaap	Payments For Restructuring PaymentsForRestructuring	448000	USD
CY2020	us-gaap	Restructuring Charges RestructuringCharges	0	USD
CY2020	us-gaap	Payments For Restructuring PaymentsForRestructuring	3561000	USD
CY2020Q4	us-gaap	Restructuring Reserve RestructuringReserve	0	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	61736000	USD
CY2020Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	68548000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	66555000	USD
CY2019Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	67437000	USD
CY2019Q1	us-gaap	Gross Profit GrossProfit	59137000	USD
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	42000	USD
CY2020Q1	us-gaap	Gross Profit GrossProfit	51711000	USD
CY2020Q2	us-gaap	Gross Profit GrossProfit	45449000	USD
CY2019Q2	us-gaap	Gross Profit GrossProfit	57688000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	38000	USD
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.48
CY2019Q3	us-gaap	Gross Profit GrossProfit	75658000	USD
CY2019Q4	us-gaap	Gross Profit GrossProfit	63691000	USD
CY2020Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1020000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	42000	USD
CY2020Q3	us-gaap	Gross Profit GrossProfit	54014000	USD
CY2020Q4	us-gaap	Gross Profit GrossProfit	57730000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-11304000	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	27000	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-309000	USD
CY2019Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	220000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-4821000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-8466000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	12379000	USD
CY2020Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-19417000	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-16580000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-13273000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-17210000	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	-7476000	USD
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.48
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2019Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2020Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
CY2019Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07

Files In Submission

Name	View Source	Status
0001376339-21-000011-index-headers.html	Edgar Link	pending
0001376339-21-000011-index.html	Edgar Link	pending
0001376339-21-000011.txt	Edgar Link	pending
0001376339-21-000011-xbrl.zip	Edgar Link	pending
ex1025equityplan20201231.htm	Edgar Link	pending
ex1035mip20201231.htm	Edgar Link	pending
ex211subsidiaries12312020.htm	Edgar Link	pending
ex231auditorconsent12312020.htm	Edgar Link	pending
ex311soxceo30220201231.htm	Edgar Link	pending
ex312soxcfo30220201231.htm	Edgar Link	pending
ex31restatedarticlesofinco.htm	Edgar Link	pending
ex321soxceo90620201231.htm	Edgar Link	pending
ex322cfosox90620201231.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
image_01.jpg	Edgar Link	pending
image_01a.jpg	Edgar Link	pending
image_11.jpg	Edgar Link	pending
mdxg-20201231.htm	Edgar Link	pending
mdxg-20201231.xsd	Edgar Link	pending
mdxg-20201231_cal.xml	Edgar Link	unprocessable
mdxg-20201231_def.xml	Edgar Link	unprocessable
mdxg-20201231_g1.jpg	Edgar Link	pending
mdxg-20201231_htm.xml	Edgar Link	completed
mdxg-20201231_lab.xml	Edgar Link	unprocessable
mdxg-20201231_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MDXG
MIMEDX GROUP, INC. Stock $mdxg

2020 Q4 Form 10-K Financial Statement

#000137633921000011 Filed on March 08, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MDXG MIMEDX GROUP, INC. Stock $mdxg

2020 Q4 Form 10-K Financial Statement

#000137633921000011 Filed on March 08, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MDXG
MIMEDX GROUP, INC. Stock $mdxg